Key points are not available for this paper at this time.
Pegfilgrastim is safe and significantly reduces the incidence of FN in breast cancer patients.
Kosaka et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: